TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive NCI, Groups Disagree Over repayment, McIntyre: NCA Could Examine Relationship of Groups To NCI December 9, 1994
